Search

everythinglearnresearchcommunity

for

Search:↓

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Isotretinoin can cause serious birth defects and needs careful use, especially in pregnant women.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

A 2-year-old boy grew excessive hair after using minoxidil for hair loss, but it improved when the treatment stopped.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Neuroregulation is crucial for skin wound healing and can be targeted to improve recovery.

Rejuvenating self-repair mechanisms could improve organ recovery in regenerative medicine.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Men with androgenetic alopecia may have higher blood pressure, suggesting early screening for hypertension.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

Androgen use may increase the risk of stroke, but more research is needed.

Zinc can reverse hair loss caused by the anthrax vaccine.

Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

The nervous system helps control stem cell behavior and immune responses, affecting tissue repair and maintenance.

Accurate testosterone measurement and standardized lab practices are crucial for diagnosing and managing adult male hypogonadism.

The study suggests that treating early hair loss with Nourkrin® with Marilex® can help prevent further hair loss and may be linked to reducing the risk of lifestyle diseases.

Effective acne treatment and patient education are crucial to prevent long-term physical and psychological effects.

New treatments for PCOS using smart drug delivery, metabolic changes, and AI show promise but need more research.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Nanocarriers can improve antioxidant delivery to the skin but face safety and production challenges.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.